Lung cancer trials in China

In China 1143 Also abroad 2747

1,143 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase II Study of GC101 in NSCLC
Where
Shanghai
Age
18 years to 70 years
People
28
Run by
Shanghai Juncell Therapeutics
See details and how to joinNCT07560111
No phaseTaking people
Effect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy
Where
Chengdu
Age
18 years and over
People
270
Run by
Chengdu Jinjiang Maternity and Child Health Hospital
See details and how to joinNCT07746323
Phase 2Taking people
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
Where
Chengdu, Suining
Age
18 years to 75 years
People
100
Run by
Sichuan University
See details and how to joinNCT07748325
Phase 1/2Taking people
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
Where
Shenzhen
Age
18 years to 75 years
People
60
Run by
Beijing Biotech
See details and how to joinNCT07744256
Phase 1/2Taking people
Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma
Where
Hangzhou
Age
18 years and over
People
15
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07744529
Phase 4Taking people
Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)
Where
Hefei
Age
18 years to 75 years
People
107
Run by
Anhui Provincial Cancer Hospital
See details and how to joinNCT07744698
Phase 2Not yet taking people in China
Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer
Where
Shanghai
Age
18 years and over
People
20
Run by
Ruijin Hospital
See details and how to joinNCT07745790
No phaseTaking people
Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients
Where
Guangzhou
Age
18 years and over
People
100
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06215326
Phase 2/3Taking people
A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)
Where
Shanghai
Age
18 years to 75 years
People
90
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07642024
Phase 2Taking people
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
Where
Shanghai
Age
18 years and over
People
160
Run by
Peng Zhang
See details and how to joinNCT07742332
No phaseNot yet taking people in China
Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
Where
Wuhan
Age
18 years and over
People
160
Run by
HAN GUANG
See details and how to joinNCT07742800
Phase 2Enrolling by invitation
Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC
Where
Fuzhou
Age
18 years to 75 years
People
20
Run by
Fujian Cancer Hospital
See details and how to joinNCT07738367
Phase 1Taking people
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Where
Beijing, Chongqing, Jinan
Age
18 years and over
People
434 worldwide
Run by
Amgen
See details and how to joinNCT07094113
Phase 2Taking people
A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
Where
Shanghai
Age
18 years to 75 years
People
70
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07308106
Phase 1/2Taking people
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
265
Run by
Akeso
See details and how to joinNCT07623356
Phase 3Taking people
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Where
Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangdong, Guangzhou, Hangzhou, Harbin, Hefei, Henan, Jinan, Jining, Nanchang, Qingdao, Shanghai, Shenyang, Taiyuan, Taizhou, Tianjin, Wuhan, Xiamen, Yinchuan
Age
18 years and over
People
756 worldwide
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06095583
Phase 2Taking people
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Where
Shenyang
Age
18 years to 75 years
People
170
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07122687
No phaseEnrolling by invitation
Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
Where
Beijing
People
354
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07373899
Phase 1Taking people
APG-2449 in Patients With Advanced Solid Tumors
Where
Beijing, Changsha, Fuzhou, Guangzhou, Hangzhou, Wuhan, Zhengzhou
Age
18 years and over
People
165
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT03917043
Phase 2Taking people
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Where
Chengdu, Hangzhou, Jinan, Nanchang, Shanghai
Age
18 years and over
People
204 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00
Phase 2Taking people
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
66
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06437509
Phase 2Taking people
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Where
Guangzhou
Age
18 years and over
People
570
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06475300
Phase 1Taking people
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
Where
Tianjin
Age
18 years and over
People
493
Run by
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07589205
Phase 1/2Taking people
Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
108
Run by
Shanghai Chest Hospital
See details and how to joinNCT07632365
Phase 1Taking people
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Where
Beijing, Shanghai
Age
18 years and over
People
714 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00